Status:
COMPLETED
Voice Adaptive Tablet-Based Naming Treatment for Adults With Aphasia
Lead Sponsor:
University of Alberta
Collaborating Sponsors:
University of Toronto
Technische Universität Berlin
Conditions:
Aphasia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Rising life expectancy is leading to a rising incidence of strokes worldwide. Approximately one third of people who had a stroke live with a communication disorder, aphasia, which is associated with t...
Detailed Description
Purpose: The purpose of the study proposed in this ethics application is to examine the impact of an adaptive speech-language treatment app, created using principles of user-centred design, on langua...
Eligibility Criteria
Inclusion
- be at least 6 months post onset of a single stroke in the left hemisphere
- have aphasia of mild to moderate severity (Aphasia Quotient ≥ 30 on WAB--R) with a prominent verbal expression impairment.
- pass screenings of visual perception (BORB), hearing (pure tone screening with portable audiometer), and basic cognitive functioning (Raven's Coloured Progressive Matrices)
- speak English as a primary language.
- be willing to commit to participation for study duration
Exclusion
- Currently participating in individual (one-on-one) speech-language therapy
Key Trial Info
Start Date :
October 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 5 2023
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT04108364
Start Date
October 1 2020
End Date
January 5 2023
Last Update
September 19 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alberta
Edmonton, Alberta, Canada, T6G2G4
2
University of Toronto
Toronto, Ontario, Canada, M5G 1V7